Clinical Trial Update: Heart Failure Optimization Study

View source ↗

Summary

The Heart Failure Optimization Study (NCT03016754), sponsored by Zoll Medical Corporation, has completed. Results were posted on 2025-03-24 and assess outcomes …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Sudden Cardiac Arrest
• Sudden Cardiac Death

Snippet

Sponsor: Zoll Medical Corporation | Conditions: Sudden Cardiac Death, Sudden Cardiac Arrest | Status: COMPLETED | Results posted: 2025-03-24